Risk factors for unfavourable treatment outcomes among rifampicin-resistant tuberculosis patients in Tajikistan.

Setting: Tajikistan is among the 30 countries with the highest multidrug-resistant tuberculosis (MDR-TB) burden.

Objective: To investigate the risk factors for unfavourable treatment outcomes among rifampicin-resistant (RR)/MDR-TB patients.

Design: Retrospective medical chart review of RR/MDR-TB patients enrolled for treatment in 2012-2013.